XML 42 R22.htm IDEA: XBRL DOCUMENT v3.25.0.1
Segment Information
 12 Months Ended
Dec. 31, 2024
Segment Reporting [Abstract]  
Segment Information Segment Information
The Company operates in two product segments: Oral, Personal and Home Care; and Pet Nutrition. 

The operations of the Oral, Personal and Home Care product segment are managed geographically in five reportable operating segments: North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.

In connection with management changes, the Company realigned the reporting structure of its skin health business effective July 1, 2024. Accordingly, commencing with the quarter ended September 30, 2024, the results of the skin health business previously reported within the Europe reportable operating segment are reported with the other skin health businesses in the North America reportable operating segment, with no impact on the Company's consolidated results of operations or financial position. The Company has recast its historical geographic segment information to conform to the new reporting structure.

The Company evaluates segment performance based on several factors, including Operating profit. The Company uses Operating profit as a measure of operating segment performance because it excludes the impact of Corporate-driven decisions related to interest expense and income taxes. The Chairman of the Board, President and Chief Executive Officer has been determined to be the Company’s Chief Operating Decision Maker who uses Operating Profit to assess performance and to allocate resources for each of the reportable operating segments in the budgeting and forecasting process. Asset information by segment is not utilized for purposes of assessing performance or allocating resources, and therefore such information has not been presented.

The accounting policies of the operating segments are generally the same as those described in Note 2, Summary of Significant Accounting Policies. Intercompany sales have been eliminated. Corporate operations include costs related to stock options and restricted stock units, research and development costs, Corporate overhead costs, restructuring and related implementation charges and gains and losses on sales of non-core product lines and assets. The Company reports these items within Corporate operations as they relate to Corporate-based responsibilities and decisions and are not included in the internal measures of segment operating performance used by the Company to measure the underlying performance of the operating segments.

Approximately two-thirds of the Company’s Net sales are generated from markets outside the U.S., with approximately 45% of the Company’s Net sales coming from emerging markets (which consist of Latin America, Asia (excluding Japan), Africa/Eurasia and Central Europe). Oral, Personal and Home Care sales to Walmart, Inc. and its affiliates represent approximately 11% of the Company’s Net sales in each of the years 2024, 2023 and 2022. No other customer represented more than 10% of Net sales in any period presented.

In 2024, Corporate Operating profit included charges resulting from the 2022 Global Productivity Initiative of $85. In 2023, Corporate Operating profit included charges resulting from the 2022 Global Productivity Initiative of $27 and product recall costs of $25. In 2022, Corporate Operating profit included goodwill and intangible assets impairment charges of $721, charges resulting from the 2022 Global Productivity Initiative of $95, a gain on the sale of land in Asia Pacific of $47 and acquisition-related costs of $19.
2024
Net salesCost of SalesSelling, general and administrative expenses
Other (income) expense, net (3)
Operating Profit
Reportable Segments
Oral, Personal and Home Care
North America(1)
$4,113 $1,571 $1,668 $36 $839 
Latin America4,782 1,933 1,328 (5)1,526 
Europe2,770 1,050 1,031 31 658 
Asia Pacific2,858 1,078 997 (30)812 
Africa/Eurasia1,095 432 395 16 253 
Total Oral, Personal and Home Care15,618 4,088 
Pet Nutrition(2)
4,483 1,869 1,641 8 965 
Reconciliation with Total Company Operating Profit
Corporate(784)
Total$20,101 $4,268 
Note: Table may not sum due to rounding.
(1) Net sales in the U.S. for Oral, Personal and Home Care were $3,640 in 2024.
(2) Net sales in the U.S. for Pet Nutrition were $3,059 in 2024.
(3) Refer to Note 16, Supplemental Income Statement for information related to Other (income) expense, net.


2023
Net salesCost of SalesSelling, general and administrative expenses
Other (income) expense, net (3)
Operating Profit
Reportable Segments
Oral, Personal and Home Care
North America(1)
$4,091 $1,588 $1,594 $37 $871 
Latin America4,640 1,977 1,241 51,417 
Europe2,571 1,069 899 31 573 
Asia Pacific2,782 1,108 925 (18)767 
Africa/Eurasia1,083 442 377 9 254 
Total Oral, Personal and Home Care15,167 3,882 
Pet Nutrition(2)
4,290 1,964 1,493 26806 
Reconciliation with Total Company Operating Profit
Corporate$(704)
Total$19,457 $3,984 
Note: Table may not sum due to rounding.
(1) Net sales in the U.S. for Oral, Personal and Home Care were $3,625 in 2023.
(2) Net sales in the U.S. for Pet Nutrition were $2,918 in 2023.
(3) Refer to Note 16, Supplemental Income Statement for information related to Other (income) expense, net.
2022
Net salesCost of SalesSelling, general and administrative expenses
Other (income) expense, net (3)
Operating Profit
Reportable Segments
Oral, Personal and Home Care
North America(1)
$4,002 $1,649 $1,567 $46 $741 
Latin America3,982 1,885 1,059 (71)1,108 
Europe2,362 1,023 778 28 534 
Asia Pacific2,826 1,160 954 (24)737 
Africa/Eurasia1,082 447 389 18 228 
Total Oral, Personal and Home Care14,254 3,348 
Pet Nutrition(2)
3,713 1,569 1,287 7850 
Reconciliation with Total Company Operating Profit
Corporate$(1,305)
Total$17,967 $2,893 
Note: Table may not sum due to rounding.
(1) Net sales in the U.S. for Oral, Personal and Home Care were $3,511 in 2022.
(2) Net sales in the U.S. for Pet Nutrition were $2,432 in 2022
(3) Refer to Note 16, Supplemental Income Statement for information related to Other (income) expense, net.


202420232022
Capital expenditures  
Oral, Personal and Home Care  
North America$52 $46 $66 
Latin America126 146 121 
Europe63 44 31 
Asia Pacific64 65 60 
Africa/Eurasia12 10 30 
Total Oral, Personal and Home Care317 311 308 
Pet Nutrition143 301 297 
Corporate101 93 91 
Total Capital expenditures$561 $705 $696 
202420232022
Depreciation and amortization  
Oral, Personal and Home Care  
North America$124 $116 $128 
Latin America100 98 93 
Europe65 65 68 
Asia Pacific81 84 89 
Africa/Eurasia8 9 9 
Total Oral, Personal and Home Care378 372 387 
Pet Nutrition132 101 65 
Corporate95 94 93 
Total Depreciation and amortization$605 $567 $545 

20242023
Long-lived assets(1)
United States$2,728 $2,733 
International2,223 2,340 
Total Long-lived assets$4,951 $5,073 
(1) Long-lived assets include Property, plant and equipment, net and lease right-of-use assets.